Today: 28 June 2026

Texas Instruments (TXN) Stock This Week and Week Ahead: Key News, Legal Headlines, and What Could Move Shares Next (Updated Dec. 12, 2025)

Texas Instruments (TXN) Stock This Week and Week Ahead: Key News, Legal Headlines, and What Could Move Shares Next (Updated Dec. 12, 2025)

Texas Instruments closed at $179.42 on Friday, down 1.24% for the day and about 0.8% for the week. The stock remains well below its 52-week high of $221.69. Multiple lawsuits were filed in Texas alleging TI chips ended up in Russian and Iranian weapons systems. Trading volume Friday was below the 50-day average.
13 December 2025
····
Circle Internet Group (CRCL) Stock: OCC Trust Bank Charter Headlines, USDC Momentum, and the Week-Ahead Setup (Updated Dec. 12, 2025)

Circle Internet Group (CRCL) Stock: OCC Trust Bank Charter Headlines, USDC Momentum, and the Week-Ahead Setup (Updated Dec. 12, 2025)

Circle Internet Group (NYSE: CRCL) shares fell 5.8% to $83.47 Friday despite announcing conditional OCC approval to form a national trust bank. The stock traded between the low-$82s and low-$91s during the session, with 13.7 million shares changing hands. CRCL is down 3% for the week and 11% for the month. Final regulatory approval for the trust bank is still pending.
13 December 2025
···
Intuitive Surgical Stock News: ISRG Drops ~4% This Week Despite FDA Clearance, Citi Downgrade, and New Price Targets (Updated Dec. 12, 2025)

Intuitive Surgical Stock News: ISRG Drops ~4% This Week Despite FDA Clearance, Citi Downgrade, and New Price Targets (Updated Dec. 12, 2025)

Intuitive Surgical shares fell 4.3% this week, closing at $542.32 Friday after five straight declines. The drop followed FDA clearance expanding da Vinci SP’s U.S. indications, a Citigroup downgrade, a Wells Fargo price-target hike, and insider selling disclosures. ISRG now trades about 12% below its 52-week high.
13 December 2025
·
Credo Technology Group (CRDO) Stock: This Week’s Pullback, Fresh Insider Filings, Analyst Targets — and the Week-Ahead Setup (Updated Dec. 12, 2025)

Credo Technology Group (CRDO) Stock: This Week’s Pullback, Fresh Insider Filings, Analyst Targets — and the Week-Ahead Setup (Updated Dec. 12, 2025)

Credo Technology Group shares fell 19.6% from $178.94 on Monday to $143.91 by Friday, December 12, 2025, after a volatile week marked by profit-taking and insider-trade headlines. The drop followed a surge earlier in December, driven by record quarterly results and raised revenue guidance tied to hyperscale AI data center demand.
13 December 2025
·
Wells Fargo (WFC) Stock: This Week’s Moves, Fresh Headlines, and the Week-Ahead Outlook (Updated Dec. 12, 2025)

Wells Fargo (WFC) Stock: This Week’s Moves, Fresh Headlines, and the Week-Ahead Outlook (Updated Dec. 12, 2025)

Wells Fargo closed Friday, Dec. 12 at $92.76, up 3% for the week after a mid-week rebound. The stock hit intraday highs of $93.42 on Thursday and Friday. Wells Fargo advanced to 8th in global M&A rankings, its first top-10 showing since 1995, amid a hiring push in investment banking. The Federal Reserve cut its target rate by 0.25 percentage point on Dec. 10.
13 December 2025
··
Analog Devices (ADI) Stock Update: Fresh 52-Week Highs, Insider Filings, Analyst Targets — What to Watch Next Week (Updated Dec. 12, 2025)

Analog Devices (ADI) Stock Update: Fresh 52-Week Highs, Insider Filings, Analyst Targets — What to Watch Next Week (Updated Dec. 12, 2025)

Analog Devices closed Friday at $279.32, down 1.44% after touching new highs near $284 earlier in the week. The stock ended nearly flat for the week, up just $0.19 from Monday. Vice President Michael Sondel disclosed selling 8,169 shares at $279.50, while Board Chair Vincent Roche filed to sell 10,000 shares under a prearranged plan. Trading volume reached 4 million, above the 50-day average.
13 December 2025
·
Merck (MRK) Stock Update: This Week’s News, Key Catalysts, and the Week-Ahead Outlook (Updated Dec. 12, 2025)

Merck (MRK) Stock Update: This Week’s News, Key Catalysts, and the Week-Ahead Outlook (Updated Dec. 12, 2025)

Merck shares closed at $100.30 on Friday, up 1.3% for the day and 0.6% for the week, rebounding after early losses tied to vaccine-policy headlines and RSV therapy scrutiny. The stock gained despite broad market declines. Merck received a positive EU CHMP opinion for expanded use of Winrevair, while the FDA launched new safety reviews of its RSV preventive therapies for infants.
13 December 2025
··
McDonald’s Stock (MCD) Today: Shares Jump to $316.72 as “Value” Strategy Tightens—What to Watch Next Week (Updated Dec. 12, 2025)

McDonald’s Stock (MCD) Today: Shares Jump to $316.72 as “Value” Strategy Tightens—What to Watch Next Week (Updated Dec. 12, 2025)

McDonald’s shares closed at $316.72 on Friday, up 2.26%, outperforming a weaker market and ending a two-day slide. The company will tighten global franchising standards on value starting Jan. 1, 2026, aiming for more consistent value delivery while franchisees retain pricing control. Trading volume Friday reached 3.8 million shares, above the 50-day average.
13 December 2025
·
Dell Technologies Stock (DELL) Weekly Update: Price Hikes, Insider Sale, and AI Server Momentum — Outlook for the Week Ahead (Updated Dec. 12, 2025)

Dell Technologies Stock (DELL) Weekly Update: Price Hikes, Insider Sale, and AI Server Momentum — Outlook for the Week Ahead (Updated Dec. 12, 2025)

Dell Technologies shares fell 7.4% for the week, closing at $129.98 on Friday amid sharp declines in hardware stocks linked to AI volatility. The company announced commercial price hikes starting Dec. 17, citing shortages in memory and storage components. Director Egon Durban sold 71,000 shares on Dec. 9 at an average price of $138.12.
13 December 2025
··
AbbVie Stock (ABBV) Weekly Update & Week-Ahead Outlook: Analyst Upgrades, Pipeline Catalysts, and Key Levels — Updated Dec. 12, 2025

AbbVie Stock (ABBV) Weekly Update & Week-Ahead Outlook: Analyst Upgrades, Pipeline Catalysts, and Key Levels — Updated Dec. 12, 2025

AbbVie shares closed Friday at $223.32, down 0.29% as the S&P 500 fell. The stock was flat for the week, trading between $220.23 and $226.12. Volume spiked Wednesday after HSBC upgraded AbbVie to “Buy” and raised its price target to $265, while Morgan Stanley also boosted its target. AbbVie and OSE Immunotherapeutics amended their partnership on ABBV-230, with OSE regaining early-stage rights.
13 December 2025
PepsiCo (PEP) Stock: This Week’s Rally, Elliott-Driven 2026 Plan, Analyst Forecasts, and the Week Ahead (Updated Dec. 12, 2025)

PepsiCo (PEP) Stock: This Week’s Rally, Elliott-Driven 2026 Plan, Analyst Forecasts, and the Week Ahead (Updated Dec. 12, 2025)

PepsiCo shares closed at $150.65 on Dec. 12, up 1.08% despite a broader market drop, capping a 3.9% weekly gain. The stock surged midweek after PepsiCo outlined 2026 cost cuts and simplification plans following pressure from Elliott Investment Management, which disclosed a 4% stake. JPMorgan also upgraded the stock. PepsiCo remains nearly 6% below its 52-week high.
13 December 2025
·
Synopsys (SNPS) Stock: Q4 Earnings Beat, Ansys Integration, and What to Watch Next Week (Updated Dec. 12, 2025)

Synopsys (SNPS) Stock: Q4 Earnings Beat, Ansys Integration, and What to Watch Next Week (Updated Dec. 12, 2025)

Synopsys shares fell 5.09% to $452.95 on Dec. 12, 2025, underperforming peers after fiscal Q4 earnings and 2026 guidance. Trading volume spiked to 2.7 million shares. The stock gave back post-earnings gains in a broader tech sell-off, ending the week down 2.75%. Q4 revenue reached $2.255 billion, topping analyst estimates.
13 December 2025
····
Citigroup Stock (C) Outlook: JPMorgan Upgrade, Turnaround Momentum, and What to Watch Next Week (Updated Dec. 12, 2025)

Citigroup Stock (C) Outlook: JPMorgan Upgrade, Turnaround Momentum, and What to Watch Next Week (Updated Dec. 12, 2025)

Citigroup shares closed Friday at $111.80, near a 52-week high, after JPMorgan upgraded the stock to “overweight” and raised its price target to $124. CFO Mark Mason said fourth-quarter investment banking fees are expected to rise by about 25% year-over-year. Investors are watching for signs that CEO Jane Fraser’s turnaround plan is driving sustained gains.
13 December 2025
·
Charles Schwab (SCHW) Stock This Week: Client Assets Hit $11.83 Trillion as the Fed Cuts Rates — What Investors Are Watching Next Week (Updated Dec. 12, 2025)

Charles Schwab (SCHW) Stock This Week: Client Assets Hit $11.83 Trillion as the Fed Cuts Rates — What Investors Are Watching Next Week (Updated Dec. 12, 2025)

Charles Schwab shares closed at $96.65 Friday, down 0.4% for the day but up 3% for the week. The company reported $40.4 billion in core net new assets for November, a 40% increase from a year earlier. Total client assets reached $11.83 trillion, up 15% year over year. Transactional sweep cash declined by $1.3 billion to $427.5 billion.
13 December 2025
··
Eaton (ETN) Stock Update Dec. 12, 2025: Virginia Data‑Center Expansion, Analyst Upgrade, Friday Selloff — and the Week Ahead

Eaton (ETN) Stock Update Dec. 12, 2025: Virginia Data‑Center Expansion, Analyst Upgrade, Friday Selloff — and the Week Ahead

Eaton Corporation shares fell 5.25% to $331.98 on Friday, Dec. 12, closing below their 200-day moving average amid heavy trading volume. The drop followed recent bullish news, including a $50 million Virginia expansion and a Wall Street upgrade, but came as investors broadly sold off data center-related stocks. No Eaton-specific negative headlines appeared Friday.
13 December 2025
1 … 1,432 1,433 1,434 1,435 1,436 … 2,115

Stock Market Today

  • Senator Mitch McConnell's Net Worth Drops $434K in Stock Market in May 2026
    June 28, 2026, 12:52 AM EDT. Senator Mitch McConnell experienced a $434,300 loss in the stock market last month, according to Quiver Quantitative's live net worth estimates. McConnell's total estimated net worth stands at $68.8 million, ranking 23rd highest in Congress. He holds approximately $49.6 million in publicly traded assets tracked by Quiver. The senator's stock trades since 2019 include significant transactions in companies like IR, VMC, LAZR, WFC, and KR, with mixed returns. McConnell recently filed $0 in fundraising but reported $7.3 million cash on hand in Q1 2026. The figures are based on financial disclosures and may not be fully accurate, per Quiver's disclaimer.

Latest articles

Hecla Mining (NYSE:HL) sees stock rebound, volume jumps as silver prices in focus

Hecla Mining (NYSE:HL) sees stock rebound, volume jumps as silver prices in focus

28 June 2026
Hecla Mining surged 5.3 times its average trading volume Friday as index rebalancing drove 112.44 million shares traded, but the stock’s 2.6% weekly drop still beat silver and peer ETFs, signaling company-specific strength; investors now watch if Hecla can hold above $15.54 without rebalancing flows as macro risks loom.
Go toTop